Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly.

导出 LinkOut

翻译打印收藏纠错

作者： Sameer R,Ghate ^[1] ; Zhiyi,Li ^[2] ; Jackson,Tang ^[2] ; Antonio Reis,Nakasato ^[3]

作者单位： Director, Health Economics and Outcomes Research, Novartis Oncology, East Hanover, NJ. ^[1] Partner, Asclepius Analytics, New York, NY. ^[2] Medical Director, Novartis Oncology. ^[3]

关键词 adverse events economic burden elderly patients immunotherapy metastatic melanoma targeted therapy treatment-related costs

PMID 30647822

发布时间 2023-10-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

American health & drug benefits

2018年11卷7期

334-343页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly.

American health & drug benefits

相似文献

American health & drug benefits

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly.

American health & drug benefits

相似文献

American health & drug benefits

相关期刊

检索历史清除